Determination of N(G)-monomethyl-L-arginine in human and dog serum using pre-column O-phthaldialdehyde derivatization and high performance liquid chromatography

Journal of Liquid Chromatography and Related Technologies

Volumn 20, Issue 12, 1997, Pages 1839-1848

  Alak, A M ^a   Moy, S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE DERIVATIVE; CITRULLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; AUTOIMMUNITY; DIAGNOSTIC ACCURACY; DOG; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATORY DISEASE; NONHUMAN;

CANIS FAMILIARIS;

EID: 0030745626     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1080/10826079708005546     Document Type: Article

References (13)

1. H. Kolb, V. Kolb-Bachofen, "Nitric Oxide: A Pathogenic Factor in Autoimmunity," Immunol. Today, 13, 157-160 (1992).
2. J. A. Corbett, R. G. Tilton, K. Chang, K. S. Hasan, Y. Ido, J. L. Wang, M. A. Sweetland, J. R. Lancaster Jr., J. R. Williamson, M. L. McDaniel, "Aminoguanidine, A Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction," Diabetes, 41, 552-556 (1992).
3. R. G. Kilbourn, O. W. Griffith, "Overproduction of Nitric Oxide in Cytokine-Mediated and Septic Shock," J. Nat. Cancer Inst., 84, 827-831 (1992).
4. A. K. Nussler, M. Di Silvo, T. R. Billiar, R. A. Hoffman, D. A. Geller, R. Selby, J. Madariaga, R. L. Simmons, " Stimulation Of Nitric Oxide Synthase Pathway In Human Hepatocytes By Cytokines And Endotoxin," J. Exp. Med, 176, 261-264 (1992).
5. E. Nava, R. M. J. Palmer, S. Moncada, "Inhibition of Nitric Oxide Synthesis in Septic Shock: How Much Is Beneficial?," Lancet, 338, 1555-1557 (1991).
6. J. Meyer, L. D. Traber, S. Nelson, C. W. Lentz, H. Nakazawa, D. N. Herndon, H. Noda, D. L. Traber, "Reversal of Hyperdynamic Response to Continuous Endotoxin Administration by Inhibition of NO Synthesis," J. Appl. Physiol., 73, 324-328 (1992).
7. A. Petros, D. Bennett, P. Vallance, "Effects of Nitric Oxide Synthase Inhibitors on Hypotension in Patients with Septic Shock," Lancet, 338, 157-1558 (1991).
8. S. A. Rosenberg, M. T. Lotze, Y. C. Yang, P. M. Aebersold, W. M. Linehan, C. A. Seipp, D. E. White, "Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients," Ann. Surg., 210, 474-484 (1989).
9. R. Lee, M. Lotze, J. Skibber, E. Tucker, R. Bonow, F. Ognibene, J. Carrasquillo, J. Shelhamer, J. Parillo, S. Rosenberg, "Cardiorespiratory Effects of Immunotherapy with Interleukin-2," J. Clin. Oncol., 7, 7-20 (1989).
10. G-Dimethylarginine from the Hydrolysate of Proteins of Boving Brain," Biochim. Biophys. Acta, 230, 212-222 (1971).
11. M-Mono, Di-, and Trimethyllysine, and Glucosylgalactosyl- and Galactosyl-L-Hydroxylysine from Human Urine," J. Biol. Chem., 245, 5751-5758 (1970).
12. K. S. Park, H.Y. Lee, S.-L. Hong, S. Shin, S. Kim, W. K. Paik, "Determination of Methylated Amino Acids in Human Serum by High Performance Liquid Chromatography," J. Chromatog., 440, 225-230 (1988).
13. B. N. Jones, S. Pääbo, S. Stein, "Amino Acid Analysis and Enzymatic Sequence Determination of Peptides by an Improved O-Phthaldialdehyde Precolumn Labeling Procedure," J. Liq. Chromatog., 4, 565-586 (1981).